Healthcare Realty Trust Incorporated (NYSE:HR) Given Average Recommendation of “Hold” by Brokerages

Healthcare Realty Trust Incorporated (NYSE:HR) has been given an average recommendation of “Hold” by the ten ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $20.25.

A number of research analysts recently commented on the stock. UBS Group upped their price target on shares of Healthcare Realty Trust from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday. Citigroup upped their price target on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Weiss Ratings lowered shares of Healthcare Realty Trust from a “hold (c)” rating to a “sell (d+)” rating in a research note on Monday, May 4th. Scotiabank upped their price target on shares of Healthcare Realty Trust from $20.00 to $22.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. Finally, Royal Bank Of Canada upped their price target on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Thursday.

Healthcare Realty Trust Stock Performance

Shares of HR stock opened at $20.27 on Wednesday. The firm’s 50-day moving average is $18.30 and its 200-day moving average is $17.79. The stock has a market cap of $7.02 billion, a price-to-earnings ratio of -34.94 and a beta of 0.97. Healthcare Realty Trust has a 52-week low of $14.09 and a 52-week high of $20.52.

Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.02. The company had revenue of $275.28 million for the quarter, compared to analysts’ expectations of $283.01 million. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. Healthcare Realty Trust’s quarterly revenue was down 7.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.39 EPS. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. Sell-side analysts predict that Healthcare Realty Trust will post 1.61 EPS for the current fiscal year.

Healthcare Realty Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 22nd. Investors of record on Monday, May 11th will be paid a $0.24 dividend. The ex-dividend date is Monday, May 11th. This represents a $0.96 dividend on an annualized basis and a yield of 4.7%. Healthcare Realty Trust’s dividend payout ratio is -165.52%.

Insider Buying and Selling

In related news, Director Thomas N. Bohjalian purchased 10,000 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was acquired at an average cost of $18.09 per share, for a total transaction of $180,900.00. Following the completion of the purchase, the director owned 85,520 shares in the company, valued at approximately $1,547,056.80. This represents a 13.24% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.56% of the company’s stock.

Institutional Investors Weigh In On Healthcare Realty Trust

Several institutional investors have recently made changes to their positions in the stock. Quantinno Capital Management LP boosted its stake in shares of Healthcare Realty Trust by 79.5% in the first quarter. Quantinno Capital Management LP now owns 270,591 shares of the real estate investment trust’s stock valued at $4,597,000 after buying an additional 119,804 shares during the period. Lazard Asset Management LLC boosted its stake in shares of Healthcare Realty Trust by 12.2% in the first quarter. Lazard Asset Management LLC now owns 100,202 shares of the real estate investment trust’s stock valued at $1,702,000 after buying an additional 10,905 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Healthcare Realty Trust by 100.0% in the first quarter. Renaissance Technologies LLC now owns 1,549,172 shares of the real estate investment trust’s stock valued at $26,320,000 after buying an additional 774,500 shares during the period. Arrowstreet Capital Limited Partnership bought a new stake in shares of Healthcare Realty Trust in the first quarter valued at approximately $500,000. Finally, Caxton Associates LLP boosted its stake in shares of Healthcare Realty Trust by 25.4% in the first quarter. Caxton Associates LLP now owns 130,781 shares of the real estate investment trust’s stock valued at $2,222,000 after buying an additional 26,510 shares during the period.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.